Android Apple

Amgen (AMGN) Rose Owing To The Announcement Of Promising Data For Its Novel Medication

By Yahoo! Finance   |   2 months ago
Amgen (AMGN) Rose Owing To The Announcement Of Promising Data For Its Novel Medication

PGIM Jennison Health Sciences Fund's Q2 2024 investor letter discussed stock performance, highlighting Amgen Inc. (NASDAQ:AMGN). The fund noted Amgen's one-month return and market capitalization. They mentioned the potential of AI stocks for higher returns compared to Amgen.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.